This page brings together haematology thesis topics and clinical haematology research topics suitable for MD/DNB Medicine residents, with designs that can usually be completed within one thesis period using routine ward, clinic, laboratory, transfusion-service and follow-up data already available in a teaching hospital. The emphasis is on feasible observational, diagnostic, audit and short prospective studies rather than resource-heavy molecular projects. Before registration, the selected question should be converted into a department-specific MD Medicine haematology protocol and MD Medicine haematology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.
Not the general medicine subspeciality you need? Haematology is one section of our full general medicine collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
📌 Updated for 2026–2027 MD/DNB Medicine Haematology admissions
The page has been reviewed for practical feasibility, current clinical relevance and methods that can be completed using routinely available haematology investigations and follow-up.
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Already have your thesis title?
Generate the full haematology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocolAlongside haematology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →Haematology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the haematology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the haematology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a haematology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A haematology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning haematology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the haematology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A haematology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the haematology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A haematology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full haematology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a haematology PhD or MMed proposal →🔥 Trending research areas in Haematology for 2026–27
Define the haematological phenotype before recruitment. The protocol should state the laboratory and clinical criteria for anaemia, thrombocytopenia, pancytopenia, haemolysis, iron deficiency, vitamin B12 deficiency, venous thromboembolism or the chosen disorder. A vague label such as "anaemia" is not enough if the analysis depends on iron deficiency, marrow failure or haemolysis.
Fix the sampling time point. Blood counts, ferritin, reticulocyte count, bilirubin, lactate dehydrogenase, coagulation tests and inflammatory markers can change rapidly after transfusion, haematinics, corticosteroids, antibiotics, hydration or acute illness. The protocol should specify whether measurements are pre-treatment, pre-transfusion, at admission, at diagnosis or at a defined follow-up visit.
State the reference standard. Screening indices such as Mentzer index, mean corpuscular volume, red-cell distribution width, D-dimer or mean platelet volume should be compared against an appropriate reference standard. The reference standard may be biochemical confirmation, haemoglobin analysis, imaging, bone marrow examination or a final clinical diagnosis, depending on the question.
Define the unit of analysis. A transfusion study may analyse patients, transfusion episodes or individual components; a recurrent crisis study may analyse patients or episodes. The protocol should choose one unit and prevent repeated observations from being treated as independent unless the analysis accounts for clustering.
The synopsis is the concise registration document. It usually states the title, rationale, objectives, design, setting, participants, key eligibility criteria, variables, sample size, analysis plan and ethical safeguards in the format required by the university or institution.
The protocol is the operational document. It should additionally define exact diagnostic criteria, timing of each blood sample, handling of prior transfusion or treatment, laboratory methods, analyser-derived variables, reference standards, follow-up windows, missing-data rules and how repeated admissions or transfusions will be handled.
Haematology requires particular attention to timing. A ferritin measured during sepsis, a haemoglobin electrophoresis obtained soon after transfusion, or a platelet count after treatment may answer a different question from the one written in the objective. Those timing rules belong in the protocol even if the synopsis mentions them only briefly.
Base the sample size on the primary objective. Prevalence studies need an expected proportion and precision; correlation studies need an anticipated correlation coefficient; comparative studies need an expected difference between groups; diagnostic studies require assumptions for sensitivity or specificity; and prospective outcome studies need an expected event rate.
Do not inflate the effective sample by counting repeated laboratory results as separate patients. If each participant contributes several transfusions, admissions or follow-up samples, the analysis should either use one prespecified observation per participant or apply a method that recognises repeated measures.
Match the test to the data structure. Continuous variables may require correlation, group comparison or regression; categorical outcomes may use chi-square, Fisher exact or logistic regression; paired pre-treatment and post-treatment values require paired analysis; diagnostic work should report sensitivity, specificity and confidence intervals against the stated reference standard.
Plan for confounding before data collection. Age, sex, infection, inflammation, chronic kidney disease, liver disease, malignancy, transfusion history and current treatment can materially alter blood counts and biomarkers, so the protocol should prespecify the most important variables rather than testing every available laboratory value.
For the 2026–2027 academic year, the most feasible topics are those built around a common patient group, a routinely ordered investigation, one clearly defined primary outcome and a sampling window that can be applied consistently. Before finalising the title, confirm the likely monthly case load, whether the key laboratory parameter is routinely available, and whether follow-up can be completed within the residency period.
Cross-sectional, comparative cross-sectional, case-control, prospective observational, retrospective record-based, diagnostic accuracy, correlation, agreement and clinical-audit designs are all commonly workable when they match the objective. A design should not be labelled cross-sectional if the primary outcome depends on change over time, treatment response, platelet recovery, recurrent thrombosis or follow-up haemoglobin.
Settle the exact case definition, primary objective, sampling time point, treatment or transfusion exclusions, reference standard, laboratory method, follow-up duration, primary statistical comparison and realistic recruitment source. For analyser-derived parameters, also confirm that the same analyser and reporting format will remain available throughout the study.
Yes, but feasibility should be checked before registration by reviewing a small sample of records for the variables needed for the primary objective. A retrospective design becomes weak when key exposures such as transfusion timing, medication adherence, bleeding severity or laboratory reference tests are missing non-randomly. The protocol should define the minimum dataset required for inclusion and how missing values will be reported.
The synopsis is the shorter document submitted for academic registration, whereas the protocol contains the detailed operating rules needed to run the study reproducibly. In haematology, the protocol should spell out diagnostic cut-offs, sampling timing, laboratory methods, effects of recent transfusion or treatment, reference standards and handling of repeated measurements.
Prospective studies require informed consent, and studies involving children should include guardian consent and age-appropriate assent from about seven years where applicable. Record-based studies may seek an ethics-approved waiver of consent when risk is minimal and confidentiality is protected. Research should not add transfusion, bone marrow aspiration, contrast exposure or venepuncture merely to create data; if an additional blood sample is scientifically necessary, the protocol should state a prespecified age- and weight-appropriate blood-volume limit. Separate consent is needed for identifiable photographs or video. Unexpected severe cytopenia, blasts, dangerous coagulation abnormalities or other clinically important incidental findings should have a named escalation pathway to the treating team or haematology service.
Recent transfusion or treatment can change the biological meaning of the measurement and should never be handled as an afterthought. The protocol should define a pre-transfusion or pre-treatment sample whenever the objective depends on baseline red-cell indices, haemoglobin fractions, reticulocytes, ferritin, platelet count or coagulation status. If post-treatment measurements are part of the objective, the interval should be fixed in advance. Participants with recent transfusion may need exclusion from particular diagnostic analyses, or separate analysis, because donor red cells can alter haemoglobin fractions and red-cell indices.
Yes, but the scope and document type should be changed rather than simply lengthening an MD synopsis. A PhD proposal usually needs a broader conceptual framework, a stronger originality argument and a larger or multi-stage methodology. Gulf training pathways may require a board research project rather than an Indian-style dissertation; this includes programmes linked to SCFHS and the Saudi Board, the Arab Board of Health Specializations, and DHP, DHA, DOH and MOHAP-linked training programmes. The same clinical question can often be adapted, but the required approvals, format, sample size and supervisor expectations should be checked against the relevant programme.
Registration should occur after the guide has confirmed case availability, laboratory access, the primary outcome, the sampling time point and the proposed analysis, but early enough to leave adequate time for ethics approval and recruitment. Topics dependent on uncommon malignancies, specialised assays or long follow-up should be screened for feasibility before formal submission.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol